PLEXAFORM Trademark
Trademark Overview
On Friday, February 17, 2023, a trademark application was filed for PLEXAFORM with the United States Patent and Trademark Office. The USPTO has given the PLEXAFORM trademark a serial number of 97800094. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 9, 2024. This trademark is owned by Saol Bermuda Development Ltd.. The PLEXAFORM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain
General Information
Serial Number | 97800094 |
Word Mark | PLEXAFORM |
Filing Date | Friday, February 17, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Monday, December 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
Goods and Services | Pharmaceuticals for the treatment of spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain |
Goods and Services | Providing information in the field of medical research; research and development of pharmaceuticals; providing information in the field of medical research related to pharmaceuticals; Educational services, namely, instruction in methods of treating spasticity, pain, pain related to osteoarthritis, pain related to cancer, pain related to post-arthroplasty procedures, occipital neuralgia, neuropathic pain, neuropathies, nerve related pain, peripheral nerve pain, chronic pain conditions, cervical pain, cervical dystonia, phantom leg pain |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 8, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 8, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Saol Bermuda Development Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Hamilton HM09 BM |
Trademark Events
Event Date | Event Description |
Tuesday, February 21, 2023 | NEW APPLICATION ENTERED |
Wednesday, March 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 16, 2023 | ASSIGNED TO EXAMINER |
Monday, November 20, 2023 | NON-FINAL ACTION WRITTEN |
Monday, November 20, 2023 | NON-FINAL ACTION E-MAILED |
Monday, November 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, February 16, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Friday, February 16, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, May 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, May 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, May 23, 2024 | FINAL REFUSAL WRITTEN |
Thursday, May 23, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Friday, June 21, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, June 21, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Friday, November 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, November 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 23, 2024 | FINAL REFUSAL E-MAILED |
Friday, November 22, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, December 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |